Hematology Conferences | Blood Disorder Conferences | USA …

6thInternational Conference on Hematology

Date:October 03-05, 2016

Venue:Orlando, Florida, USA

Hematology 2016 has been designed with many interesting and informative scientific sessions; it includes all possible aspects of Hematology research.

Hematology

Erythrocytesare also known as red blood cells which carry oxygen to the body and collect carbon dioxide from the body by the use of hemoglobin and its life span of 120 days. along the side the leucocytes helps in protecting the healthy cells because the W.B.C (leucocytes) act as the defending cells in protecting the immune system from the foreign cells. Theseleucocytesare multipotent cells in bone marrow and there life span is of 3-4 days where the yellow blood cells are called as thrombocytes they are where small and irregular in shape they have life span of 5-9 days they are mostly seen in mammals they help in clotting of blood which are in fibrin form called as thrombosis these lead to heart stroke, blockage of blood in blood mostly in arms and legs. where C.B.C is known ascomplete blood countis done to know the number of cells in a body these are mainly done by lab technician presently they are been tested by automatic analyzer the high and low amount of cells will lead to many diseases. Decrease of R.B.C in the body these causes of anemia which leads to weakness, feeling of tired, shortness of breath and person will be noticeably pale. Formation of blood cellular components are called as Hematopoiesis and all the cellular blood components are derived from hematopoiesis stem cells in a healthy individual nearly 10111012new blood cells are produced these help in steady peripheral circulation. If there is a increases of R.B.C in the body these causes polycythemia these can be measured through hematocrit level.

Recomended:Hematology Conferences

International Conference onGenetic CounselingandGenomic MedicineAugust 11-12, 2016, UK; International Conference onClinicalandMolecular GeneticsNovember 28-30, 2016, USA; 5thInternational Conference and Exhibition onCellandGene TherapyMay 19-21, 2016, USA; World Congress onHuman GeneticsOctober 31- November 02, 2016, Spain; International Conference onNext Generation SequencingJuly 21-22, 2016, Germany; 58th ASH Annual Meeting & Exposition December 3-6, 2016 San Diego, CA; ESH 2016 Annual Meeting June 10 13, 2016 Paris, France; ASH Conferences on Lymphoma Biology June 18 - 21, 2016 ESH 5th International Conference on Myelodysplastic Syndromes April 14 April 16, 2016 Estoril, Portugal; European Society ofHuman Genetics: ESHG Conferences May 21-24, 2016, Spain; American Society ofHuman Genetics;ASHG Annual Meeting October 6-10, 2015, Maryland.

Blood Disorders

Hemophilia Ais a genetic deficiency in clottingfactor VIII,which causes increased bleeding and usually affects males. About 70% of the time it is inherited as an X-linked recessive trait, but around 30% of cases arise from spontaneous mutations. Hemophilia B is ablood clottingdisorder caused by amutationof thefactor IXgene, leading to a deficiency of factor IX. It is the second-most common form ofhaemophilia, rarer thanhaemophilia A. It is sometimes calledChristmas disease, named afterStephen Christmas, the first patient described with this disease.In addition, the first report of its identification was published in the Christmas edition of theBritish Medical Journal.Hemophilia C is a mild form of haemophiliaaffecting both sexes. However, it predominantly occurs in Jews ofAshkenazidescent. It is the fourth most common coagulationdisorder aftervon Willebrand's diseaseandhaemophiliaAandB.In theUSAit is thought to affect 1 in 100,000 of the adult population, making it 10% as common as haemophilia A. Idiopathic thrombocytopenic purpura(ITP), also known asimmune thrombocytopenia,primary immune thrombocytopenia,primary immune thrombocytopenic purpuraorautoimmune thrombocytopenic purpura, is defined as isolated low platelet count (thrombocytopenia) with normalbone marrowand the absence of other causes of thrombocytopeniaVon Willebrand diseasesis the most common hereditarycoagulationabnormality described in humans. Platelets also called "thrombocytes" areblood cellswhose function (along with thecoagulation factors) is to stop bleeding by clumping and clogging blood vessel injuries.Platelets have nocell nucleus: Coagulation is highlyconservedthroughout biology; in allmammals, coagulation involves both a cellular (platelet) and aprotein(coagulation factor) component and these are occoured due togenetic blood disorders

Recomended: Blood Disorder Conferences

6thInternational Conference onHematologyOctober 03-05, 2016 Orlando, Florida, USA;4thInternational Conference onBlood Malignanciesand TreatmentApril 18-19, 2016, UAE;International Conference onLeukemiaandBone marrow TransplantationNovember 10-12, 2016 Turkey; 7thHealth Careand Fitness SummitSeptember 26-28, 2016, UK; NHF 67th Annual Meeting, Dallas, August 13-15, 2015 USA; European HemophiliaConsortium: EHC Conference, 02-04 October 2015, Serbia;ASH Meeting on Lymphoma Biology June 18 - 21, 2016 Colorado Springs, CO; Hemophilia& Thrombosis Research Society : HTRS Scientific Symposium, 25-26 November 2015, USA ; Society ofThrombosis and Haemostasis Research: GTH Annual Meeting 1 7- 20 Feb 2016, Germany ; American Society ofHematology: ASH Annual Meeting & Exposition December 5-8, 2015 USA ESH 7th International Conference on Myeloproliferative Neoplasms October 27 - October 29, 2016 Estoril, Portugal

Hematologic Malignancies

Lymphatic leukemiawhich effect the white blood cells(w.b.c) they are closely related to the lymphomas and some of them are unitary diseases which related to the adult T cells leukemia these come under the lymphoproliferative disorders. Mostly they involve in the B-cell sub type lymphocytes. The myeloid leukemia is preferred to the granulocyte precursor in the bone marrow and spinal cord and these arises the abnormal growth in the blood from tissues in the bone marrow. They are mainly related to the hematopoietic cells and these sub title into acute and chronic lymphoblastic leukemia. The acute leukemia is that rapidly producing immature blood cells as they are bulk number of cells healthy cells are not produced in bone marrow due this spill over the blood stream which spread to other body parts. Where as in chronic leukemia highly bulid of matured cells are formed but still abnormal white cells are formed these can not be treated immediately mostly seen in older people. The cancer which originate from white blood cells are called as lymphoma and this disorder is mainly seen inHodgkin lymphomathese diseases is treated by radiation and chemotherapy, orhematopoietic stem cell transplantation. The cancer which starts with in the cell are called as Non Hodgkin lymphocytes and these lymphocytes are of lymph nodes. The bone marrow which develops too many white blood cells leads tomultiple myleoma. The further details on malignance are been discussed inHematology oncology conference-2015.

Recomended: Blood CancerConferences

4thInternational Conference onBlood Malignancies& Treatment April 18-20 2016,UAE ; 5thworld Hematologists Congress June 06-08 2016,UK ; International Conference onLeukemiaandBone marrow TransplantationNov 10-12 2016, Turkey ; 8thEuro Global Summit onCancer TherapyNovember 03-05 2015,Spain; 10thGlobal AnnualOncologists MeetingJuly 11-13 2016, Germany;6thInternational Conference onHematology October 03-05, Orlando, Florida USA; Global Summit & Expo onHealth careNovember 9-11 2015,UAE ; International Conference onInternal MedicineNovember 03-05, 2016 ,USA ; ASH Meeting on Hematologic Malignancies September 15 - 17, 2016 Chicago, IL; ESH Conferences: 18th Annual John Goldman Conference onChronic Myeloid Leukemia: Biology and Therapy, Sep 15 - 18, 2016, US; The 26thRegional congress of the ISBT November 14-16 2015, Indonesia ; Texas Bleeding Disorders Conference November 8 2015 ,Texas ; ASH 3rd International Conference on Multiple Myeloma October 07 - October 09, 2016 Milan, Italy; 7th International Hematologic Malignancies Conference: Bridging the Gap February 27-28, 2016, China; 14th International Conference onMalignant Lymphoma, Jun 14-17,2016; 6th ESMOSarcoma& GIST Conference, 16-17 February 2016, Italy; International Conference onAgingand Hematological Malignancies: Biology and Therapy ,March 11 - March 13, 2016, Greece; ESH 2nd International Conference on New Concepts in B-Cell Malignancies, September 09 - 11, 2016, Portugal.

Hematology and immunology

Blood groupsare of ABO type and but at present the Rh blood grouping of 50 well defined antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to. The disorder of immune system leading to hypersensitivity is called asClinical Immunologyand the abnormal growth of an infection are known as Inflammation and the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.

Recomended: Haematology Conferences

International Conference onMucosalImmunology, July 28-29, 2016, Australia; International Conference onAllergy, March 29-30, 2016, Spain; 2nd International Congress onNeuroimmunology&Therapeutics, March 31-Apr 2, 2016, USA; 2nd International Conference onInnate Immunity, July 21-22, 2016, Germany; EuropeanImmunologyConference, July 21-23, 2016, Germany; 9th EuropeanMucosal ImmunologyGroup Meeting, October 9 - 12 October, Scotland; International congress onImmunology, August 21-26, 2016, Australia; International Symposium On B Cells:ImmunityAndAutoimmunity, 1-3 October, 2015, Erlangen, German; 4th European Congress ofImmunologySeptember 6-9, 2015, Austria.

Blood Transplantation

Theumbilical cordis a conduit between the developingembryoorfetusand theplacenta. The umbilical vein supplies the fetus with nutrient-richbloodfrom theplacenta The hematopoitic bone marrow transplant, the HSC are removed from a large bone of the donor, typically thepelvis, through a largeneedlethat reaches the center of the bone. Acute myeloid leukemia is a cancerof themyeloidline of blood cells, characterized by the rapid growth of abnormalwhite blood cellsthat accumulate in thebone marrowand interfere withthe production of normal blood cells and the Thrombosis is the formation of ablood clot inside ablood vessel, obstructing the flow ofbloodthrough thecirculatory system. TheHemostaticis a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing. Metabolic syndromeis a disorder of energy utilization and storage, diagnosed by a co-occurrence of three out of five of the following medical conditions, obesity,elevated blood pressure,elevated fasting plasma glucose,high serum triglycerides, and lowhigh-density lipoprotein(HDL) levels. Metabolic syndrome increases the risk developingcardiovascular diseaseanddiabetes.

Recomended: Blood Transplantation Conferences

6thInternational Conference on Hematology at Florida, USA October 03-05, 2016. 4thInternational conference onBlood malignanceand TreatmentatUAE from April 18-19, 2016. Global Summit onMelanomaand Carcinoma at Australia from July 14-15, 2016.Cancer DiagnosticsConference & Expoat Rome, Italy from June 13-15, 2016. 2nd International Conference and Exhibition onMolecular Medicineand Diagnostics, at USA from September 26-28, 2016. Society forHaematologyandstem cells44th annual scientific meeting 2015, atJapan from September 17-19, 2015. Hellenic Society ofHaematology 26thNational Congress 2015 at Athens from November 12th14th, 2015. British Society forHaemostasisand Thrombosis Annual Meeting 2015 at UK from November 12th-14th, 2015. Society for Immunotherapy of Cancer's Advances inCancer Immunotherapy2015 at USA on December 4th2015. American Society ofHaematology57th Annual Meeting 2015 at USA from December 5th 8th, 2015. Scripps 36th Annual ConferenceClinical Haematology& Oncology 2016 at USA from February 13th 16th, 2016.

Diagnosis and Treatment

Palliative careis amultidisciplinary approachto specialisedmedical carefor people with seriousillnesses The spleen, similar in structure to a largelymph node, acts as a blood filter. Anticoagulants(antithrombics) are a class of drugs that work to prevent thecoagulation(clotting) of blood. Some anticoagulants are used in medical equipment, such astest tubes ,blood transfusionbags, andrenal dialysisequipment. Anvena cava filteris a type of vascular filter, amedicaldevice that is implanted byinterventional radiologistsor vascular surgeons into theinferior vena cavato presumably prevent life-threateningpulmonary emboliistherapyusingionizing radiation, generally as part of cancer treatmentto control or killmalignantcells. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. The subspecialty ofoncologythat focuses on radiotherapy is calledradiation oncology. Translational research is another term fortranslated researchandtranslational science, Applying knowledge from basic science is a major stumbling block in science, partially due to the compartmentalization within science. Targeted drug delivery is a method of deliveringmedicationto a patient in a manner that increases theconcentrationof the medication in some parts of the body relative to others.

Related Conferences

5thInternational Conference and Exhibition onCellandGene TherapyMay 19-21, 2016, USA; International Conference onLeukemiaandBone marrow TransplantationNovember 10-12, 2016 Turkey; World Congress onHuman GeneticsOctober 31- November 02, 2016, Spain; International Conference onNext Generation SequencingJuly 21-22, 2016, Germany; International Conference onClinicalandMolecular GeneticsNovember 28-30, 2016, USA; 11th Annual Cell &Gene TherapyForum 26 -28 February 2016 UK; 17th International Conference on Cell andGene TherapyParis, France; July 20 - 21, 2015; 9th AustralasianGene TherapySociety Meeting (AGTS) 13 - 16 May 2015 Australia; European Society ofHuman Genetics: ESHG Conferences May 21-24, 2016, Spain; 19th Training Course on HaemopoieticStem Cell TransplantationMay 21-23, 2015, Spain

New Drug Development in Haematology

The development of antibiotic resistance in particular stems from the drugs targeting only specific bacterial molecules. Because the drugisso specific, any mutation in these molecules will interfere with or negate its destructive effect, resulting in antibiotic resistance. Known asDrug deliveryConditions treated with combination therapy includetuberculosis,leprosy,cancer,malaria, andHIV/AIDS. One major benefit of combination therapies is that they reduce development ofdrug resistance, since a pathogen or tumor is less likely to have resistance to multiple drugs simultaneously.Artemisinin-based monotherapies for malaria are explicitly discouraged to avoid the problem of developing resistance to the newer treatment. Drug Induced Blood Disorders causes of sickle cell anemia,pale skin non steroids antiinflammatory drugswhich causes ulcers Using drug repositioning, pharmaceutical companies have achieved a number successes, for examplePfizer'sViagrainerectile dysfunctionandCelgene'sthalidomidein severe erythema nodosum leprosum. Smaller companies, including Ore Pharmaceuticals,Biovista, Numedicus,Melior Discoveryand SOM Biotech are also performing drug repositioning on a systematic basis. These companies use a combination of approaches including in silico biology and in vivo/in vitro experimentation to assess a compound and develop and confirm hypotheses concerning its usage for new indications.

Related Conferences

7thHealth CareandFitness ConferenceSeptember 26-28, 2016, UK; 3rd International Conference onHealth Informaticsand TechnologyJune 27-29, 2016, USA; World Congress onPublic Health&NutritionMarch 10-12, 2016, Spain; Global Summit and Expo onHealthcareNovember 09-11, 2015, UAE; 8th Global Summit and Expo onHealthcareOctober 13-15, 2016, UAE; HTI LABS ConnectedHealthConference 2015, 18 Sep 2015, United Kingdom; 9thVaccine& ISV Congress 18-20 October 2015, South Korea; ComprehensiveDentistryand the Dental Team, 714 November 2015 United States;MedicinesOptimisation 21 September 2015, United Kingdom; EHWBC EmployeeHealthand Wellbeing Conference, 11 - 13 October 2015 Qatar

Hematology Research

Lymphatic diseasesthis is a type of cancer of the lymphatic system. It can start almost any where in the body. It's believed to be caused by HIV, Epstein-Barr Syndrome, age and family history. Symptoms include weight loss, fever, swollen lymph nodes, night sweats, itchy skin, fatigue, chest pain, coughing and/or trouble swallowing. Thelymphatic systemis part of thecirculatory system, comprising a network oflymphatic vesselsthat carry a clear fluid called lymph directionally towards the heart. The lymphatic system was first described in the seventeenth century independently byOlaus RudbeckandThomas Bartholin. Unlike thecardiovascular systemthe lymphatic system is not a closed system. The human circulatory system processes an average of 20 litres ofbloodper day throughcapillary filtrationwhich removesplasmawhile leaving theblood cells. Roughly 17 litres of the filtered plasma get reabsorbed directly into the blood vessels, while the remaining 3 litres are left behind in theinterstitial fluid. One of the main functions of the lymph system is to provide an accessory return route to the blood for the surplus 3 litres. Lymphatic diseases are ofNon-Hodgkin's Lymphoma, Hodgkins. Thethymusis a specialized primarylymphoidorgan of theimmune system. Within the thymus,T cellsor Tlymphocytesmature. T cells are critical to theadaptive immune system, where the body adapts specifically to foreign invaders.One of the example of lymph node development. Formation oflymph nodeinto the tumor which lead to cancer called oncology.

Related Conferences

6thInternational Conference onCell&Stem Cell Research, Feb 29-March 02 2016, USA ; International Conference onInternal MedicineNovember 03-05, 2016 ,USA ; 4thInternational Conference onBlood Malignancies& Treatment April 18-20 2016,UAE; 3rdInternational conference onHematology&Blood DisordersNovember2-4 2015,USA ; International Conference onLeukemiaandBone marrow TransplantationNov 10-12 2016, Turkey ; 6thInternational Conference onHematologyandLymphNov 14-16, 2016;10thGlobal AnnualOncologists MeetingJuly 11-13 2016, Germany ;International Conference onInternal MedicineNovember 03-05, 2016,USA; 7thInternational conference onBiomarkers&Clinical ResearchNovember 28-30 2016,USA ; 8thEuro Global Summit onCancer TherapyNovember 03-05 2015,Spain; EMBLStem CellsConference 2016 Jun 3 - 5 2016,Germany ; 20thInternational Congress on Hematological Malignancies, March 18 20 2016,FL ; Conference onMyeloma& Lymphoma October 2015,New York ; ASH Meeting on Hematologic Malignancies Sep 17-19 2015,USA ; NCCN 10th Annual Congress: Hematologic Malignancies October 16 17 2015,USA;Congress of the International Society ofPaediatric OncologyOct 8-9 2015, South Africa;20th World Congress on Advances inOncology, October 8-10 2015,Greece; CombinationTherapies in CancerConference: Tools and Techniques for Developing Combinations More Efficiently Dec 06- 09 2015, UK

Various Aspects of Haematology

Pediatric Haematology and Oncologyis an internationalpeer-reviewedmedical journalthat covers all aspects ofpediatrichematologyandoncology. The journal covers immunology, pathology, and pharmacology in relation to blood diseases and cancer in children and shows how basic experimental research can contribute to the understanding of clinical problems. Physicians specialized in hematology are known ashematologistsorhaematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the hematology laboratory viewingblood filmsandbone marrowslides under themicroscope, interpreting various hematological test results andblood clotting testresults. In some institutions, hematologists also manage the hematology laboratory. Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologistsorhaematopathologists.Experimental Hematologyis apeer-reviewedmedical journalofhematology, which publishesoriginal researcharticles and reviews, as well as the abstracts of the annual proceedings of theSociety for Hematology and Stem Cells and they should be done under theHematology guidlines.

Related Conferences

Cancer Diagnostics Conference& ExpoJune 13-15 2016,Italy ; International Conference onInternal MedicineNovember 03-05, 2016 ,USA ; 4thInternational Conference onBlood Malignancies& Treatment April 18-20 2016,UAE ; 3rdInternational conference onHematology&Blood DisordersNovember 2-4 2015,USA ; International Conference onLeukemiaandBone marrow TransplantationNov 10-12 2016, Turkey ; 7thInternational conference onBiomarkers&Clinical ResearchNovember 28-30 2016,USA ; 8thEuro Global Summit onCancer TherapyNovember 03-05 2015,Spain; 9th Indo Global Summit onCancer Therapy, November 02-04, 2015 Hyderabad, India; Children Vaccines Conference2016 Oct 10-12, 2016 Rome, Italy; 2nd International Conference on Antimicrobial Agents andChemotherapyJune 06-07, 2016, USA; Cancer GenomeFebruary 7-11, 2016; VI Inter American Oncology Conference 'Current Status and Future ofTherapies, October 8-9th, 2015;Fourth AACR International Conference on Frontiers in BasicCancer ResearchOctober 23 26 2015,Philadelphia ; 2015 Chabner Colloquium: Collaboration in CancerDrug Trials2627 October 2015, United States ; American Society forClinical PathologyAnnual Meeting Oct 28-30 ,USA ; SITCs 30th Anniversary Annual Meeting & Associated Programs November 4 8, 2015,US ; CancerDiagnosticsConference; San Francisco Nov 16-17 2015, United States; Cancerand Metabolism September 28 - 30, 2015,UK; Stem Cell Research & Regenerative Medicine Conference,2526 April 2016,USA;

Blood Based Products

Ablood substituteis a substance used to mimic and fulfill some functions ofbiologicalblood. It aims to provide an alternative toblood transfusion, which is transferring blood orblood-based productsfrom one person into another. Thus far, there are no well-acceptedoxygen-carryingblood substitutes, which is the typical objective of ared blood celltransfusion; however, there are widely available non-bloodvolume expandersfor cases where only volume restoration is required. These are helping doctors and surgeons avoid the risks of disease transmission and immune suppression, address the chronic blood donor shortage, and address the concerns of Jehovah's Witnesses and others who have religious objections to receiving transfused blood.Pathogen reductionusing riboflavin and UV lightis a method by which infectiouspathogensinblood for transfusionare inactivated by addingriboflavinand irradiating withUV light. This method reduces the infectious levels of disease-causing agents that may be found in donated blood components, while still maintaining good quality blood components for transfusion. This type of approach to increase blood safety is also known as pathogen inactivation in the industry. Anartificial cellorminimal cellis an engineered particle that mimics one or many functions of abiological cell. The term does not refer to a specific physical entity, but rather to the idea that certain functions or structures of biological cells can be replaced or supplemented with a synthetic entity. Often, artificial cells are biological or polymeric membranes which enclose biologically active materials. As such,nanoparticles,liposomes,polymersomes, microcapsules and a number of other particles have qualified as artificial cells.Manufacturing of semi synthetic products of drugs are known as therapeutic biological products.Anticoagulants(antithrombics) are a class of drugs that work to prevent thecoagulation(clotting) of blood. Such substances occur naturally in leeches and blood-sucking insects.

Related Conferences

7thHealth CareandFitness ConferenceSeptember 26-28, 2016, UK; 3rd International Conference onHealth Informaticsand TechnologyJune 27-29, 2016, USA; World Congress onPublic Health&NutritionMarch 10-12, 2016, Spain; Global Summit and Expo onHealthcareNovember 09-11, 2015, UAE; 8th Global Summit and Expo onHealthcareOctober 13-15, 2016, UAE; HTI LABS ConnectedHealthConference 2015, 18 Sep 2015, United Kingdom; 9thVaccine& ISV Congress 18-20 October 2015, South Korea; ComprehensiveDentistryand the Dental Team, 714 November 2015 United States;MedicinesOptimisation 21 September 2015, United Kingdom; EHWBC EmployeeHealthand Wellbeing Conference, 11 - 13 October 2015 Qatar

Summary

Hematology is a branch of biology that includes various research areas such as pathology, internal medicine, clinical laboratory, physiology, immunology and pediatrics. This conference will witness a conglomeration of various arenas in Hematology and as it involves a vast range of medical streams within it, this conference will be an excellent platform for interdisciplinary interactions, to exchange and share knowledge under a single roof.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Hematology 2016, where you will be sure to have a meaningful experience with scholars from around the world.

For more details please visit: http://hematology.conferenceseries.com/

Importance & Scope:

Hematology 2016,Orlando, Florida, USAis expected to offer the best platform for the expertise, researchers, students and business delegates with its well organized scientific program covering every minute detail about hematology and blood diseases, from the basic causes behind blood diseases to the latest trends in diagnostic and treatment of blood diseases. This international event is an effort to find a weapon against chronic disorders like blood cancer, Sickle cell anemia, hemophilia, lymphoma and myeloma and to discuss the role of Immunoglobulin in blood, antibody and antigen reactions, the red blood cell and the immunological properties of blood which gives a better insight about the associated causes and disease portfolio.

Conferenceseries LLC welcomes all the hematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Hematology 2016. Advanced Diagnostic and therapeutic equipment along with the novel drugs for the blood diseases are an integral part of the Hematology research, hence it will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

Why Orlando?

Orlando is a city in the U.S. state of Florida, and the county seat of Orange County. Located in Central Florida, it is the center of the Orlando metropolitan area, which had a population of 2,134,411 at the 2010 census, making it the 26th largest metropolitan area in the United States, the sixth largest metropolitan area in the Southern United States, and the third largest metropolitan area in the state of Florida. In 2010, Orlando had a city-proper population of 238,300, making it the 77th largest city in the United States, the fifth largest city in Florida, and the states largest inland city.

The City of Orlando is nicknamed The City Beautiful and its symbol is the fountain at Lake Eola. Orlando is also known as The Theme Park Capital of the World and in 2014 its tourist attractions and events drew more than 62 million visitors. The Orlando International Airport (MCO) is the thirteenth busiest airport in the United States and the 29th busiest in the world. Buddy Dyer is Orlandos mayor. Orlandos famous attractions form the backbone of its tourism industry: Walt Disney World Resort, located approximately 21 miles (34 km) southwest of Downtown Orlando in Bay Lake, opened by the Walt Disney Company in 1971; the Universal Orlando Resort, opened in 1999 as a major expansion of Universal Studios Florida; SeaWorld; Gatorland; and Wet n Wild. With the exception of Walt Disney World, most major attractions are located along International Drive. The city is also one of the busiest American cities for conferences and conventions.

Conference Highlights

A Unique Opportunity for Advertisers and Sponsors at this International event

http://hematology.conferenceseries.com/sponsors.php

Associations in USA

Associations Worldwide

Universities in USA

Universities Worldwide

Companies in USA

Hospitals in USA

Hospitals in Worldwide

Glance at Market of Hematology

According to market study, market value of Hematology at present is $15.13 billion. A major part of research is going on at the top Universities across the globe, the grants allotted for this research field is around $10.54 billion. Many companies are associated with the blood testing equipment along with various diagnostic instruments, hematologic drugs and other therapeutics, the revenue generated is around $21.1 billion on average by this companies. Besides this various societies and research labs are also associated in this research field. More than 40% research work on Hematology is going on in USA, as around 176 Universities in USA are working in this field, along with 24 Societies, besides that there are almost 40 companies in USA which deals with diagnostic and testing equipment. Market value of Hematology at present in USA is $3.13 billion at present, university grants allotted by government is about $2.10 billion and average revenue generated by the industries in USA is $8.1billion. The global hematology market is divided into hematology products& hematology services. The hematology products segment holds the largest share of the hematology market in 2016. It is also expected to grow at the highest growth rate by next five years, owing to the increasing development of new hematology reagents. In addition, based on the end-users, the global hematology market has been segmented into commercial organizations, stand-alone hospitals, research institutes, and clinical testing labs. The clinical testing labs hold the largest share of the hematology market in 2016.

"3rd International Conference on Hematology & Blood Disorders" organized by OMICS Group International was successfully held at Double Tree by Hilton Hotel Atlanta Airport at Atlanta, USA during November 02-04, 2015. The conference was organized around the theme Research strategies, advanced technologies and upcoming challenges in Hematology."

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 25 different countries ultimately driving the event into the path of success.

OMICS Group International would like to convey a warm gratitude to all the honorable guests of Hematology-2015, Robert H Schiestl University of California, USA; C Cameron Yin University of Texas, USA; Dianzheng Zhang, Philadelphia College of Osteopathic Medicine, USA;Jay S Raval, University of North Carolina, USA and Robert Michael Davidson The American Institute of Stress, USA

The highlights of the conference were its educative and effectual keynote lectures by:

Robert H Schiestl, University of California, USA

C Cameron Yin , University of Texas, USA

Knox Van Dyke, West Virginia University, USA

Knox Van Dyke,West Virginia University, USA

Robert Michael Davidson , The American Institute of Stress, USA

OMICS Group also took the privilege of felicitating Hematology-2015 Organizing Committee, Editorial Board Members and Keynote Speakers whose support led the conference into the path of excellence. Our special gratitude to our media partnersAll Congress,Business Vibes,Clocate, Medical News Today,Oncology Education and ORIC Publications.

Hematology-2014

"2ndInternational Conference on Hematology & Blood Disorders" organized by OMICS Group International was successfully held at Double Tree by Hilton Hotel BWI Airport at Baltimore, USA during September 29- October 01, 2014. The conference was organized around the themeOn the Path of Identifying Novel Therapeutics for Blood Disorders."

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 25 different countries ultimately driving the event into the path of success.

OMICS Group International would like to convey a warm gratitude to all the honorable guests of Hematology-2014, Mark Roschewski, National Institutes of Health, USA; E. Brad Thompson, University of Houston, USA; Britt Gustafsson, Center for Allogeneic Stem Cell Transplantation, Sweden; Effie Liakopoulou, Genimbi Inc, USA and Ping Xie, Rutgers University, USA

The highlights of the conference were its educative and effectual keynote lectures by:

OMICS Group also took the privilege of felicitating Hematology-2014 Organizing Committee, Editorial Board Members and Keynote Speakers whose support led the conference into the path of excellence. Our special gratitude to our exhibitorOne Lambda, USA and media partnersAll Congress,Business Vibes,Clocate, Medical News Today,Oncology Education and ORIC Publications.

Hematology-2013

"2ndInternational Conference on Hematology & Blood Disorders" organized by OMICS Group International was successfully held at Double Tree by Hilton Hotel BWI Airport at Baltimore, USA during September 29- October 01, 2014. The conference was organized around the themeOn the Path of Identifying Novel Therapeutics for Blood Disorders."

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 25 different countries ultimately driving the event into the path of success.

OMICS Group International would like to convey a warm gratitude to all the honorable guests of Hematology-2014, Mark Roschewski, National Institutes of Health, USA; E. Brad Thompson, University of Houston, USA; Britt Gustafsson, Center for Allogeneic Stem Cell Transplantation, Sweden; Effie Liakopoulou, Genimbi Inc, USA and Ping Xie, Rutgers University, USA

The highlights of the conference were its educative and effectual keynote lectures by:

OMICS Group also took the privilege of felicitating Hematology-2014 Organizing Committee, Editorial Board Members and Keynote Speakers whose support led the conference into the path of excellence. Our special gratitude to our exhibitorOne Lambda, USA and media partnersAll Congress,Business Vibes,Clocate, Medical News Today,Oncology Education and ORIC Publications.

Read the original post:
Hematology Conferences | Blood Disorder Conferences | USA ...